Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CISD1 | Q9NZ45 | 2/20 | 0.63 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | TYR | P14679 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.34 |
| ▸ | LMNA | P02545 | 4/20 | 0.34 |
| ▸ | CA12 | O43570 | 4/20 | 0.34 |
| ▸ | CA1 | P00915 | 4/20 | 0.34 |
| ▸ | CA2 | P00918 | 4/20 | 0.34 |
| ▸ | CA7 | P43166 | 4/20 | 0.34 |
| ▸ | CA9 | Q16790 | 4/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.34 |
| ▸ | CA3 | P07451 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30526137 | 0.91 | CISD1 (0.56) | CISD1PTGS2LCKBACE1TYR | |
| SCHEMBL379093 | 0.85 | CISD1 (0.54) | CISD1PTGS2TYRGAAGLA | |
| SCHEMBL31578652 | 0.85 | CISD1 (0.54) | CISD1PTGS2BACE1GAAKDM4E | |
| SCHEMBL7763063 | 0.85 | CISD1 (0.54) | CISD1PTGS2LCKTYRGAA | |
| SCHEMBL9053013 | 0.84 | CISD1 (0.50) | CISD1TYRGAAGLACA1 | |
| SCHEMBL31467447 | 0.79 | CISD1 (1.00) | CISD1PTGS2TYRGAAKDM4E | |
| SCHEMBL18091201 | 0.79 | CISD1 (1.00) | CISD1PTGS2TYRGAAKDM4E | |
| SCHEMBL30912677 | 0.79 | CISD1 (0.87) | CISD1PTGS2LCKTYRGAA | |
| SCHEMBL21247190 | 0.79 | CISD1 (1.00) | CISD1PTGS2TYRGAAKDM4E | |
| SCHEMBL19469516 | 0.79 | CISD1 (1.00) | CISD1PTGS2TYRGAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250162986-A1 | Compounds and compositions for neurodegenerative diseases | UNIVERSIDADE NOV A DE LISBOA (PT) | 2025-05-22 | — | — | US | claimed |
| EP-4482483-A1 | COMPOUNDS AND COMPOSITIONS FOR NEURODEGENERATIVE DISEASES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2025-01-01 | — | — | EP | claimed |
| CN-118742304-A | Compounds and compositions for neurodegenerative diseases | 里斯本新大学 | 2024-10-01 | — | — | CN | claimed |
| WO-2023156983-A1 | COMPOUNDS AND COMPOSITIONS FOR NEURODEGENERATIVE DISEASES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2023-08-24 | — | — | WO | claimed |
| EP-4230201-A1 | COMPOSITION FOR TREATING NEURODEGENERATIVE DISEASES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2023-08-23 | — | — | EP | claimed |
| WO-2000014603-A1 | PROCESS FOR PREPARING A COLOR FILTER OR OVERLAY | POLAROID CORPORATION (US) | 2000-03-16 | — | — | WO | claimed |
| WO-2000014602-A1 | PROCESS FOR FORMING A COLOR FILTER | POLAROID CORPORATION (US) | 2000-03-16 | — | — | WO | claimed |
| US-20250162986-A1 | Compounds and compositions for neurodegenerative diseases | UNIVERSIDADE NOV A DE LISBOA (PT) | 2025-05-22 | — | — | US | disclosed |
| CN-119325372-A | Phloroglucinol formulations and methods of use | 辛菲特罗制药有限公司 | 2025-01-17 | — | — | CN | disclosed |
| EP-4482483-A1 | COMPOUNDS AND COMPOSITIONS FOR NEURODEGENERATIVE DISEASES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2025-01-01 | — | — | EP | disclosed |
| CN-118742304-A | Compounds and compositions for neurodegenerative diseases | 里斯本新大学 | 2024-10-01 | — | — | CN | disclosed |
| WO-2023156983-A1 | COMPOUNDS AND COMPOSITIONS FOR NEURODEGENERATIVE DISEASES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2023-08-24 | — | — | WO | disclosed |
| WO-2023156983-A1 | COMPOUNDS AND COMPOSITIONS FOR NEURODEGENERATIVE DISEASES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2023-08-24 | — | — | WO | disclosed |
| EP-4230201-A1 | COMPOSITION FOR TREATING NEURODEGENERATIVE DISEASES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2023-08-23 | — | — | EP | disclosed |
| CN-111675683-A | Preparation method of proanthocyanidin polymer and proanthocyanidin polymer | 西北农林科技大学 | 2020-09-18 | — | — | CN | disclosed |
| US-7737308-B1 | Methods for nitrating compounds | ALLIANT TECHSYSTEMS INC. (US) | 2010-06-15 | — | — | US | disclosed |
| US-20030027060-A1 | Photoresist and process for structuring such a photoresist | LEDERER KAY (DE) | 2003-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250162986-A1 | Compounds and compositions for neurodegenerative diseases | CLN6, HTT, SNCA | CISD1 2185/4885PTGS2 2256/4885LCK 3606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.